SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices

0
146
SK Biopharmaceuticals

Summation

  • SK Biopharmaceuticals, an innovative global pharmaceuticals company, announced that its digital wearable devices – Zero WiredTM and Zero EarbudsTM – have won the Red Dot Design Award 2023 in the healthcare category for outstanding design.
  • Zero WiredTM and Zero GlassesTM earned the CES® 2023 Innovation Awards for outstanding design and engineering from the Consumer Technology Association, the host of the world’s biggest tech exhibition CES, in November, 2022.
  • Zero WiredTM, a wired device connectable to mobile phones, and Zero EarbudsTM, an earbud device adjustable to fit various head sizes, measure bio-signals from brain activity, heart rhythm, and body movement.

SK Biopharmaceuticals, an innovative global pharmaceuticals company, announced that its digital wearable devices – Zero WiredTM and Zero EarbudsTM – have won the Red Dot Design Award 2023 in the healthcare category for outstanding design.

The Red Dot Design Award is one of the world’s top design competitions that recognizes products for their design, aesthetics, functionality, impact, and innovation.

Zero WiredTM, a wired device connectable to mobile phones, and Zero EarbudsTM, an earbud device adjustable to fit various head sizes, measure bio-signals from brain activity, heart rhythm, and body movement.

SK Biopharmaceuticals is developing five wearable devices under the so-called “Project ZeroTM,”[1] aimed at optimizing its digital healthcare business model and ecosystem. The project’s name is derived from the company’s key mission to strive for the potential of “zero seizures” for patients with epilepsy.

Winning the Red Dot Design Award is the second global accolade achieved by the company for its wearable devices. Zero WiredTM and Zero GlassesTM earned the CES® 2023 Innovation Awards for outstanding design and engineering from the Consumer Technology Association, the host of the world’s biggest tech exhibition CES, in November, 2022.